A Clinical Study of Tobradex AF

Phase 3

Completed

• Conditions: Cataract

• Registration Number: NCT00473070
• Lead Sponsor: Alcon Research

Brief Summary

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-11
• Primary Completion: 2007-02
• Study First Submitted: 2007-05-10
• Study First Submitted QC: 2007-05-10
• Study First Posted: 2007-05-14
• Status Verified: 2008-07
• Last Update Submitted: 2008-07-28
• Last Update Posted: 2008-07-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 900

Inclusion Criteria

• Adult patients requiring cataract surgery

Exclusion Criteria

• Age related

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Concentration of dexamethasone in aqueous humor following a single topical ocular administration	Periodic

Secondary Outcome Measures

Name	Time	Method
Changes in external and internal ocular structures, intraocular pressure, vision and other side effects	Periodic

Trial Locations

Locations (1)

Pittsburgh; 🇺🇸 Pittsburgh, Pennsylvania, United States